Host response to influenza virus: Protection versus immunopathology

Current Opinion in Immunology

Volumn 22, Issue 4, 2010, Pages 475-481

  Peiris, J S M ^a,b   Hui, Kenrie P Y ^a   Yen, Hui Ling ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b HKU PASTEUR RESEARCH CENTRE   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; GEMFIBROZIL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR TYPE I; INTERLEUKIN 17 RECEPTOR; INTERLEUKIN 6; MESALAZINE; PIOGLITAZONE; SPHINGOSINE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; ZANAMIVIR;

ADAPTIVE IMMUNITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CROSS REACTION; CYTOKINE RELEASE; CYTOPATHOLOGY; CYTOTOXIC T LYMPHOCYTE; DRUG EFFICACY; HOST RESISTANCE; HUMAN; IMMUNOPATHOGENESIS; INFECTION PREVENTION; INFLUENZA; INFLUENZA A (H1N1); INFLUENZA A (H5N1); INNATE IMMUNITY; LUNG INJURY; NONHUMAN; PANDEMIC INFLUENZA; REVIEW; SEASONAL INFLUENZA; SURVIVAL RATE; VIRUS CELL INTERACTION; VIRUS LOAD; VIRUS PNEUMONIA; VIRUS REPLICATION; ZOONOSIS;

ADAPTIVE IMMUNITY; ANIMALS; BIRDS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; HUMANS; IMMUNITY, INNATE; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA, HUMAN;

EID: 77955661784     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2010.06.003     Document Type: Review

References (61)

1. La Gruta N.L., Kedzierska K., Stambas J., Doherty P.C. A question of self-preservation: immunopathology in influenza virus infection. Immunol Cell Biol 2007, 85:85-92.
2. Peiris J.S., Cheung C.Y., Leung C.Y., Nicholls J.M. Innate immune responses to influenza A H5N1: friend or foe?. Trends Immunol 2009, 30:574-584.
3. Taubenberger J.K., Morens D.M. The pathology of influenza virus infections. Annu Rev Pathol 2008, 3:499-522.
4. Ekiert D.C., Bhabha G., Elsliger M.A., Friesen R.H., Jongeneelen M., Throsby M., Goudsmit J., Wilson I.A. Antibody recognition of a highly conserved influenza virus epitope. Science 2009, 324:246-251.
5. Hancock K., Veguilla V., Lu X., Zhong W., Butler E.N., Sun H., Liu F., Dong L., DeVos J.R., Gargiullo P.M., et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009, 361:1945-1952.
6. Mizuguchi M., Yamanouchi H., Ichiyama T., Shiomi M. Acute encephalopathy associated with influenza and other viral infections. Acta Neurol Scand Suppl 2007, 186:45-56.
7. Warren-Gash C., Smeeth L., Hayward A.C. Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review. Lancet Infect Dis 2009, 9:601-610.
8. Gill J.R., Sheng Z.M., Ely S.F., Guinee D.G., Beasley M.B., Suh J., Deshpande C., Mollura D.J., Morens D.M., Bray M., et al. Pulmonary pathologic findings of fatal 2009 pandemic influenza A/H1N1 viral infections. Arch Pathol Lab Med 2010, 134:235-243.
9. Abdel-Ghafar A.N., Chotpitayasunondh T., Gao Z., Hayden F.G., Nguyen D.H., de Jong M.D., Naghdaliyev A., Peiris J.S., Shindo N., et al. Update on avian influenza A (H5N1) virus infection in humans. N Engl J Med 2008, 358:261-273. Writing Committee of the Second World Health Organization Consultation on Clinical Aspects of Human Infection with Avian Influenza AV.
10. Cowling B.J., Chan K.H., Fang V.J., Lau L.L.H., So T.H.C., Fung R.O.P., Ma E.S.K., Kwong A.S.K., Chan C.W., Tsui W.W.S., et al. Epidemiology of pandemic and seasonal influenza A in 2009 within households. New Eng J Med 2010, 362:2175-2184.
11. To K.K., Hung I.F., Li I.W., Lee K.L., Koo C.K., Yan W.W., Liu R., Ho K.Y., Chu K.H., Watt C.L., et al. Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection. Clin Infect Dis 2010, 50:850-859.
12. Vaillant L., La Ruche G., Tarantola A., Barboza P. Epidemic intelligence team at In VS: Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009. Euro Surveill 2009, 14.
13. Karlsson E.A., Sheridan P.A., Beck M.A. Diet-induced obesity impairs the T cell memory response to influenza virus infection. J Immunol 2010, 184:3127-3133.
14. Itoh Y., Shinya K., Kiso M., Watanabe T., Sakoda Y., Hatta M., Muramoto Y., Tamura D., Sakai-Tagawa Y., Noda T., et al. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 2009, 460:1021-1025.
15. Munster V.J., de Wit E., van den Brand J.M., Herfst S., Schrauwen E.J., Bestebroer T.M., van de Vijver D., Boucher C.A., Koopmans M., Rimmelzwaan G.F., et al. Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets. Science 2009, 325:481-483.
16. Maines T.R., Jayaraman A., Belser J.A., Wadford D.A., Pappas C., Zeng H., Gustin K.M., Pearce M.B., Viswanathan K., Shriver Z.H., et al. Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice. Science 2009, 325:484-487.
17. Perrone L.A., Plowden J.K., Garcia-Sastre A., Katz J.M., Tumpey T.M. H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice. PLoS Pathog 2008, 4:e1000115.
18. Tumpey T.M., Szretter K.J., Van Hoeven N., Katz J.M., Kochs G., Haller O., Garcia-Sastre A., Staeheli P. The Mx1 gene protects mice against the pandemic 1918 and highly lethal human H5N1 influenza viruses. J Virol 2007, 81:10818-10821.
19. Crowe C.R., Chen K., Pociask D.A., Alcorn J.F., Krivich C., Enelow R.I., Ross T.M., Witztum J.L., Kolls J.K. Critical role of IL-17RA in immunopathology of influenza infection. J Immunol 2009, 183:5301-5310.
20. Imai Y., Kuba K., Neely G.G., Yaghubian-Malhami R., Perkmann T., van Loo G., Ermolaeva M., Veldhuizen R., Leung Y.H., Wang H., et al. Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell 2008, 133:235-249.
21. Ge X., Tan V., Bollyky P.L., Standifer N.E., James E.A., Kwok W.W. Assessment of seasonal influenza A virus-specific CD4 T-cell responses to 2009 pandemic H1N1 swine-origin influenza A virus. J Virol 2010, 84:3312-3319.
22. Kreijtz J.H., de M.G., van Baalen C.A., Fouchier R.A., Osterhaus A.D., Rimmelzwaan G.F. Cross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus. J Virol 2008, 82:5161-5166.
23. Tu W., Mao H., Zheng J., Liu Y., Chiu S.S., Qin G., Chan P.L., Lam K.T., Guan J., Zhang L., et al. Cytotoxic T lymphocytes established by seasonal human influenza cross-react against 2009 pandemic H1N1 influenza virus. J Virol 2010.
24. Kim K.D., Zhao J., Auh S., Yang X., Du P., Tang H., Fu Y.X. Adaptive immune cells temper initial innate responses. Nat Med 2007, 13:1248-1252.
25. Guarda G., Dostert C., Staehli F., Cabalzar K., Castillo R., Tardivel A., Schneider P., Tschopp J. T cells dampen innate immune responses through inhibition of NLRP1 and NLRP3 inflammasomes. Nature 2009, 460:269-273.
26. Aldridge J.R., Moseley C.E., Boltz D.A., Negovetich N.J., Reynolds C., Franks J., Brown S.A., Doherty P.C., Webster R.G., Thomas P.G. TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection. Proc Natl Acad Sci U S A 2009, 106:5306-5311.
27. McGill J., Van R.N., Legge K.L. Protective influenza-specific CD8 T cell responses require interactions with dendritic cells in the lungs. J Exp Med 2008, 205:1635-1646.
28. Ramana C.V., Cheng G.S., Kumar A., Kwon H.J., Enelow R.I. Role of alveolar epithelial early growth response-1 (Egr-1) in CD8+ T cell-mediated lung injury. Mol Immunol 2009, 47:623-631.
29. Weaver C.T., Harrington L.E., Mangan P.R., Gavrieli M., Murphy K.M. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 2006, 24:677-688.
30. Bermejo-Martin J.F., Ortiz de L.R., Pumarola T., Rello J., Almansa R., Ramirez P., Martin-Loeches I., Varillas D., Gallegos M.C., Seron C., et al. Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza. Crit Care 2009, 13:R201.
31. McKinstry K.K., Strutt T.M., Buck A., Curtis J.D., Dibble J.P., Huston G., Tighe M., Hamada H., Sell S., Dutton R.W., et al. IL-10 deficiency unleashes an influenza-specific Th17 response and enhances survival against high-dose challenge. J Immunol 2009, 182:7353-7363.
32. Sun J., Madan R., Karp C.L., Braciale T.J. Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10. Nat Med 2009, 15:277-284.
33. Snelgrove R.J., Goulding J., Didierlaurent A.M., Lyonga D., Vekaria S., Edwards L., Gwyer E., Sedgwick J.D., Barclay A.N., Hussell T. A critical function for CD200 in lung immune homeostasis and the severity of influenza infection. Nat Immunol 2008, 9:1074-1083.
34. Rygiel T.P., Rijkers E.S., de R.T., Stolte E.H., van dV, Rimmelzwaan G.F., Boon L., van Loon A.M., Coenjaerts F.E., Hoek R.M., et al. Lack of CD200 enhances pathological T cell responses during influenza infection. J Immunol 2009, 183:1990-1996.
35. Alberts R., Srivastava B., Wu H., Viegas N., Geffers R., Klawonn F., Novoselova N., do Valle T.Z., Panthier J.J., Schughart K. Gene expression changes in the host response between resistant and susceptible inbred mouse strains after influenza A infection. Microbes Infect 2010, 12:309-318.
36. Boon A.C., deBeauchamp J., Hollmann A., Luke J., Kotb M., Rowe S., Finkelstein D., Neale G., Lu L., Williams R.W., et al. Host genetic variation affects resistance to infection with a highly pathogenic H5N1 influenza A virus in mice. J Virol 2009, 83:10417-10426.
37. Chan M.C., Chan R.W., Yu W.C., Ho C.C., Yuen K.M., Fong J.H., Tang L.L., Lai W.W., Lo A.C., Chui W.H., et al. Tropism and innate host responses of the 2009 pandemic H1N1 influenza virus in ex vivo and in vitro cultures of human conjunctiva and respiratory tract. Am J Pathol 2010, 176:1828-1840.
38. Osterlund P., Pirhonen J., Ikonen N., Ronkko E., Strengell M., Makela S.M., Broman M., Hamming O.J., Hartmann R., Ziegler T., et al. Pandemic H1N1 2009 influenza A virus induces weak cytokine responses in human macrophages and dendritic cells and is highly sensitive to the antiviral actions of interferons. J Virol 2010, 84:1414-1422.
39. Woo P.C., Tung E.T., Chan K.H., Lau C.C., Lau S.K., Yuen K.Y. Cytokine profiles induced by the novel swine-origin influenza A/H1N1 virus: implications for treatment strategies. J Infect Dis 2010, 201:346-353.
40. Sandbulte M.R., Boon A.C., Webby R.J., Riberdy J.M. Analysis of cytokine secretion from human plasmacytoid dendritic cells infected with H5N1 or low-pathogenicity influenza viruses. Virology 2008, 381:22-28.
41. Chan M.C., Chan R.W., Yu W.C., Ho C.C., Chui W.H., Lo C.K., Yuen K.M., Guan Y.I., Nicholls J.M., Peiris J.S. Influenza H5N1 virus infection of polarized human alveolar epithelial cells and lung microvascular endothelial cells. Respir Res 2009, 10:102.
42. Ng Y.P., Lee S.M., Cheung T.K., Nicholls J.M., Peiris J.S., Ip N.Y. Avian influenza H5N1 virus induces cytopathy and proinflammatory cytokine responses in human astrocytic and neuronal cell lines. Neuroscience 2010, 168:613-623.
43. Hui K.P., Lee S.M., Cheung C.Y., Ng I.H., Poon L.L., Guan Y., Ip N.Y., Lau A.S., Peiris J.S. Induction of proinflammatory cytokines in primary human macrophages by influenza A virus (H5N1) is selectively regulated by IFN regulatory factor 3 and p38 MAPK. J Immunol 2009, 182:1088-1098.
44. Lee S.M., Cheung C.Y., Nicholls J.M., Hui K.P., Leung C.Y., Uiprasertkul M., Tipoe G.L., Lau Y.L., Poon L.L., Ip N.Y., et al. Hyperinduction of cyclooxygenase-2-mediated proinflammatory cascade: a mechanism for the pathogenesis of avian influenza H5N1 infection. J Infect Dis 2008, 198:525-535.
45. Lee S.M., Gardy J.L., Cheung C.Y., Cheung T.K., Hui K.P., Ip N.Y., Guan Y., Hancock R.E., Peiris J.S. Systems-level comparison of host-responses elicited by avian H5N1 and seasonal H1N1 influenza viruses in primary human macrophages. PLoS One 2009, 4:e8072.
46. Baskin C.R., Bielefeldt-Ohmann H., Tumpey T.M., Sabourin P.J., Long J.P., Garcia-Sastre A., Tolnay A.E., Albrecht R., Pyles J.A., Olson P.H., et al. Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus. Proc Natl Acad Sci USA 2009, 106:3455-3460.
47. Cameron C.M., Cameron M.J., Bermejo-Martin J.F., Ran L., Xu L., Turner P.V., Ran R., Danesh A., Fang Y., Chan P.K., et al. Gene expression analysis of host innate immune responses during lethal H5N1 infection in ferrets. J Virol 2008, 82:11308-11317.
48. Mok K.P., Wong C.H., Cheung C.Y., Chan M.C., Lee S.M., Nicholls J.M., Guan Y., Peiris J.S. Viral genetic determinants of H5N1 influenza viruses that contribute to cytokine dysregulation. J Infect Dis 2009, 200:1104-1112.
49. Shapira S.D., Gat-Viks I., Shum B.O., Dricot A., de Grace M.M., Wu L., Gupta P.B., Hao T., Silver S.J., Root D.E., et al. A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection. Cell 2009, 139:1255-1267.
50. Schmolke M., Viemann D., Roth J., Ludwig S. Essential impact of NF-kappaB signaling on the H5N1 influenza A virus-induced transcriptome. J Immunol 2009, 183:5180-5189.
51. Mao H., Tu W., Qin G., Law H.K., Sia S.F., Chan P.L., Liu Y., Lam K.T., Zheng J., Peiris M., et al. Influenza virus directly infects human natural killer cells and induces cell apoptosis. J Virol 2009, 83:9215-9222.
52. Mao H., Tu W., Liu Y., Qin G., Zheng J., Chan P.L., Lam K.T., Peiris J.S., Lau Y.L. Inhibition of human natural killer cell activity by influenza virions and hemagglutinin. J Virol 2010, 84:4148-4157.
53. Alleva L.M., Cai C., Clark I.A. Using complementary and alternative medicines to target the host response during severe influenza. Evid Based Complement Altern Med 2009.
54. Marsolais D., Hahm B., Walsh K.B., Edelmann K.H., McGavern D., Hatta Y., Kawaoka Y., Rosen H., Oldstone M.B. A critical role for the sphingosine analog AAL-R in dampening the cytokine response during influenza virus infection. Proc Natl Acad Sci USA 2009, 106:1560-1565.
55. Zheng B.J., Chan K.W., Lin Y.P., Zhao G.Y., Chan C., Zhang H.J., Chen H.L., Wong S.S., Lau S.K., Woo P.C., et al. Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus. Proc Natl Acad Sci USA 2008, 105:8091-8096.
56. Grebe K.M., Takeda K., Hickman H.D., Bailey A.L., Embry A.C., Bennink J.R., Yewdell J.W. Cutting edge: sympathetic nervous system increases proinflammatory cytokines and exacerbates influenza A virus pathogenesis. J Immunol 2010, 184:540-544.
57. Khoufache K., LeBouder F., Morello E., Laurent F., Riffault S., Andrade-Gordon P., Boullier S., Rousset P., Vergnolle N., Riteau B. Protective role for protease-activated receptor-2 against influenza virus pathogenesis via an IFN-gamma-dependent pathway. J Immunol 2009, 182:7795-7802.
58. Kandun I.N., Tresnaningsih E., Purba W.H., Lee V., Samaan G., Harun S., Soni E., Septiawati C., Setiawati T., Sariwati E., et al. Factors associated with case fatality of human H5N1 virus infections in Indonesia: a case series. Lancet 2008, 372:744-749.
59. Ludwig S. Targeting cell signalling pathways to fight the flu: towards a paradigm change in anti-influenza therapy. J Antimicrob Chemother 2009, 64:1-4.
60. Belser J.A., Wadford D.A., Pappas C., Gustin K.M., Maines T.R., Pearce M.B., Zeng H., Swayne D.E., Pantin-Jackwood M., Katz J.M., et al. Pathogenesis of pandemic influenza A (H1N1) and triple-reassortant swine influenza A (H1) viruses in mice. J Virol 2010, 84:4194-4203.
61. Tumpey T.M., Basler C.F., Aguilar P.V., Zeng H., Solorzano A., Swayne D.E., Cox N.J., Katz J.M., Taubenberger J.K., Palese P., et al. Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science 2005, 310:77-80.